---
annotations:
- type: Pathway Ontology
  value: kinase mediated signaling pathway
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Ryanmiller
description: MAPK6 and MAPK4 (also known as ERK3 and ERK4) are vertebrate-specific
  atypical MAP kinases.  Atypical MAPK are less well characterized than their conventional
  counterparts, and are generally classified as such based on their lack of activation
  by MAPKK family members. Unlike the conventional MAPK proteins, which contain a
  Thr-X-Tyr motif in the activation loop, MAPK6 and 4 have a single Ser-Glu-Gly phospho-acceptor
  motif (reviewed in Coulombe and Meloche, 2007; Cargnello et al, 2011).  MAPK6 is
  also distinct in being an unstable kinase, whose turnover is mediated by ubiquitin-dependent
  degradation (Coulombe et al, 2003; Coulombe et al, 2004). The biological functions
  and pathways governing MAPK6 and 4 are not well established.  MAPK6 and 4 are phosphorylated
  downstream of class I p21 activated kinases (PAKs) in a RAC- or CDC42-dependent
  manner (Deleris et al, 2008; Perander et al, 2008; Deleris et al, 2011; De La Mota-Peynado
  et al, 2011). One of the only well established substrates of MAPK6 and 4 is MAPKAPK5,
  which contributes to cell motility by promoting the HSBP1-dependent rearrangement
  of F-actin (Gerits et al, 2007; Kostenko et al, 2009a; reviewed in Kostenko et al,
  2011b).  The atypical MAPKs also contribute to cell motility and invasiveness through
  the NCOA3:ETV4-dependent regulation of MMP gene expression (Long et al, 2012; Yan
  et al, 2008; Qin et al, 2008).  Both of these pathways may be misregulated in human
  cancers (reviewed in Myant and Sansom, 2011; Kostenko et al, 2012)  View original
  pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5687128 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3307
- /instance/WP3307
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3307.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: MAPK6 and MAPK4 (also known as ERK3 and ERK4) are vertebrate-specific
    atypical MAP kinases.  Atypical MAPK are less well characterized than their conventional
    counterparts, and are generally classified as such based on their lack of activation
    by MAPKK family members. Unlike the conventional MAPK proteins, which contain
    a Thr-X-Tyr motif in the activation loop, MAPK6 and 4 have a single Ser-Glu-Gly
    phospho-acceptor motif (reviewed in Coulombe and Meloche, 2007; Cargnello et al,
    2011).  MAPK6 is also distinct in being an unstable kinase, whose turnover is
    mediated by ubiquitin-dependent degradation (Coulombe et al, 2003; Coulombe et
    al, 2004). The biological functions and pathways governing MAPK6 and 4 are not
    well established.  MAPK6 and 4 are phosphorylated downstream of class I p21 activated
    kinases (PAKs) in a RAC- or CDC42-dependent manner (Deleris et al, 2008; Perander
    et al, 2008; Deleris et al, 2011; De La Mota-Peynado et al, 2011). One of the
    only well established substrates of MAPK6 and 4 is MAPKAPK5, which contributes
    to cell motility by promoting the HSBP1-dependent rearrangement of F-actin (Gerits
    et al, 2007; Kostenko et al, 2009a; reviewed in Kostenko et al, 2011b).  The atypical
    MAPKs also contribute to cell motility and invasiveness through the NCOA3:ETV4-dependent
    regulation of MMP gene expression (Long et al, 2012; Yan et al, 2008; Qin et al,
    2008).  Both of these pathways may be misregulated in human cancers (reviewed
    in Myant and Sansom, 2011; Kostenko et al, 2012)  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5687128
    Reactome].
  keywords:
  - p-KALRN:p-S189
  - 'UBC(1-76) '
  - 'PSMD9 '
  - 'PAK2 '
  - Protein Kinase A,
  - 'PSMD4 '
  - MAPK6
  - CDC42:GTP,RAC1:GTP:PAK1,PAK2,PAK3
  - ATP
  - 'PRKACG '
  - 'PSMB7 '
  - MAPKAPK5 gene:MYC
  - MAPKAPK5
  - 'RAG2 '
  - RHO GTPases activate
  - PAK1,2,3:CDC42:GTP,
  - 'p-KALRN '
  - PAK1,2,3
  - 'UBC(305-380) '
  - 'UBA52(1-76) '
  - 'RAG2 gene '
  - 'PSMB10 '
  - 'PSMC2 '
  - 'PSMC6 '
  - CDC42:GTP, RAC1:GTP
  - 'PSMD1 '
  - 'PSMD2 '
  - 'PSMC1 '
  - SEPT7
  - FOXO1
  - 'GTP '
  - ADP
  - RAG1,2
  - 'p-S186 MAPK4 '
  - 'PSMD5 '
  - 'RAC1 '
  - MYC
  - 'PSMC5 '
  - 'UBC(533-608) '
  - MAPK4 mRNA
  - 'MYC '
  - 'p-S857 NCOA3 '
  - 'p-S215 FOXO1 '
  - 'MIR34B gene '
  - RAG1,2 genes
  - 'UBB(77-152) '
  - 'PAK1 '
  - MAKPAPK5
  - JUN
  - DNAJB1
  - unknown ubiquitin
  - 'CCND3 '
  - 'PSMD13 '
  - 'p-S141,T402-PAK2 '
  - 'PSMD11 '
  - p-S215 FOXO1
  - MIR34B,C genes
  - 'UBC(609-684) '
  - 'PSMD10 '
  - p-T161-CDK1
  - 'p-S115 MAPKAPK5 '
  - 'p-CDC42EP2 '
  - 'UBC(229-304) '
  - 'TNRC6A '
  - 'PSMB9 '
  - 'EIF2C1 '
  - 'PSMD6 '
  - FOXO3
  - IGF2BP1
  - 'MAPK4 mRNA '
  - p-T182 MAPKAPK5
  - signaling
  - 'PSMC4 '
  - 'RAG1 gene '
  - gene
  - 'PSMD3 '
  - MAPKAPK5 gene
  - CDC42EP2,3,5
  - 'UBC(77-152) '
  - KALRN:p-S189
  - KALRN
  - 'MAPK6 '
  - p-S215 FOXO3
  - 'UBC(381-456) '
  - 'p-S154,T436-PAK3 '
  - 'p-CDC42EP5 '
  - 'PSME2 '
  - p-S115 MAPKAPK5
  - 'CDC42EP5 '
  - MAPK4
  - 'MAPK6 gene '
  - 'PSME3 '
  - p-CDC42EP2,3,5
  - 'TNRC6B '
  - 'PSME4 '
  - 'DNAJB1 '
  - p-S857 NCOA3
  - 'PSMB6 '
  - 'PSMB1 '
  - 'CDC42 '
  - 'PSMD14 '
  - 'RPS27A(1-76) '
  - 'PSMF1 '
  - 'p-S MAPK6,4 '
  - 'MIR34C gene '
  - 'EIF2C4 '
  - p-S MAPK6,4
  - 26S proteasome
  - 'p-S149,S151,S171 DNAJB1 '
  - 'KALRN '
  - p-S MAPK6,4:p-T182
  - catalytic subunits
  - 'MAPKAPK5 '
  - p-S,T-PAK1,2,3
  - 'TNRC6C '
  - 'PSMA7 '
  - 'CDC42EP2 '
  - MAPKAPK5:DNAJB1
  - 'p-S189 MAPK6 '
  - p-S215
  - 'CDC14B '
  - p-S215 FOXO1:RAG1,2
  - 'PSMB4 '
  - p-S78,S82 HSPB1
  - 'PSMA2 '
  - 'PAK3 '
  - 'PSMB3 '
  - 'miR-34C '
  - 'PSMD8 '
  - p-T182
  - 'JUN '
  - PAK1,2,3 dimer
  - CDC14A, B
  - p-S857
  - JUN:MAPK6 gene
  - H2O
  - MAPKAPK5:p-S149,S151, S171 DNAJB1
  - 'PSMA4 '
  - IGF2BP1:MAPK4 mRNA
  - NCOA3
  - 'PSMA1 '
  - p-3S,T MAPK6
  - 'RAG1 '
  - p-S MAPK6,4:MAKPAPK5
  - Ub
  - p-S189 MAPK6
  - MAPK6,4
  - 'MOV10 '
  - p-S857 NCOA3:ETV4
  - RAC1:GTP
  - 'EIF2C3 '
  - 'PSMA5 '
  - MMP2,10 genes
  - 'PSMA6 '
  - 'SHFM1 '
  - 'MAPK4 '
  - Pi
  - 'PSMB11 '
  - 'PSMB2 '
  - ligase
  - MAPK6:p-T182
  - p-S MAPKAPK5
  - 'MMP10 gene '
  - 'PRKACB '
  - 'SEPT7 '
  - 'PSMB5 '
  - MAPK4,6
  - 'UBC(457-532) '
  - 'AGO2 '
  - SEPT7:p-S189
  - HSPB1
  - miR-34B,C RISC
  - 'PSMD7 '
  - 'UBC(153-228) '
  - PAKs
  - 'MAPK6,4 '
  - 'PSME1 '
  - 'p-S144,T423-PAK1 '
  - 'MAPKAPK5 gene '
  - XPO1
  - ETV4
  - MAPK6:CDC14A,B
  - p-T182-MAPKAPK5
  - 'PSMC3 '
  - 'p-3S,T MAPK6 '
  - 'p-S215 FOXO3 '
  - p-3S,T
  - 'PSMA3 '
  - 'CDC14A '
  - 'UBB(1-76) '
  - PIP3 activates AKT
  - 'PSMD12 '
  - FOXO3:MIR34B,C
  - 'MMP2 gene '
  - 'PRKACA '
  - 'UBB(153-228) '
  - 'p-T182-MAPKAPK5 '
  - NOCA3:ETV4:MMP2,10
  - MAPK6 gene
  - 'miR-34B '
  - MYC mRNA
  - 'p-CDC42EP3 '
  - CCND3
  - 'PSMA8 '
  - 'ETV4 '
  - 'IGF2BP1 '
  - 'p-T182 MAPKAPK5 '
  - 'PSMB8 '
  - 'CDC42EP3 '
  - genes
  - ub-MAPK6
  - MAPK6:CCND3
  license: CC0
  name: MAPK6/MAPK4 signaling
seo: CreativeWork
title: MAPK6/MAPK4 signaling
wpid: WP3307
---